leisure time -WSS

leisure time

author：entertainment 2025-09-30 17:05:08 - browse：368

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： WATCH: Why do our ears pop?

focus

knowledge

focus

WSS

Obamacare plans could cover weight loss drugs

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Ukraine seeks to reclaim its role as a hub for clinical trials

MD Anderson's Padmanee Sharma responds to research credit suit

Obamacare plans could cover weight loss drugs

'The Exorcist' director William Friedkin dead at 87

focus

leisure time

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Walensky prepares to leave CDC — and Congress — behind

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Biden will tout long

23andMe had bad news about my health. I wish a person had delivered it

The UK government moves asylum

Continuity nursing helped my family in our darkest PICU moments

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

hotspot

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Moderna hits safety problems in bold bid to reinvent medicine

Reporting on presidential health from Reagan to Trump and Biden

Reporting on presidential health from Reagan to Trump and Biden

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

focus

knowledge

focus

leisure time